Cargando…
Utility of a partially covered metal stent for salvage sealing therapy for bleeding caused by duodenal invasion of pancreatobiliary cancers: Case series
Pancreatobiliary cancer‐related gastrointestinal bleeding caused by duodenal invasion can be a life‐threatening condition that is hard to control. It is unclear whether a covered self‐expandable metal stent (CSEMS) is useful for hemostasis of bleeding related to advanced pancreatobiliary cancer. The...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256867/ https://www.ncbi.nlm.nih.gov/pubmed/37304247 http://dx.doi.org/10.1002/deo2.253 |
_version_ | 1785057198178566144 |
---|---|
author | Yamashita, Yasunobu Yamazaki, Hirofumi Kawaji, Yuki Tamura, Takashi Hatamaru, Keiichi Itonaga, Masahiro Ashida, Reiko Kitano, Masayuki |
author_facet | Yamashita, Yasunobu Yamazaki, Hirofumi Kawaji, Yuki Tamura, Takashi Hatamaru, Keiichi Itonaga, Masahiro Ashida, Reiko Kitano, Masayuki |
author_sort | Yamashita, Yasunobu |
collection | PubMed |
description | Pancreatobiliary cancer‐related gastrointestinal bleeding caused by duodenal invasion can be a life‐threatening condition that is hard to control. It is unclear whether a covered self‐expandable metal stent (CSEMS) is useful for hemostasis of bleeding related to advanced pancreatobiliary cancer. The aim of this study was to evaluate the utility of a CSEMS for hemostasis of bleeding caused by duodenal invasion of pancreatobiliary cancer. Between January 2020 and January 2022, seven patients in whom a duodenal CSEMS was inserted to control pancreatobiliary cancer‐related bleeding were enrolled. The technical and clinical success rates with respect to hemostasis, procedure time, and adverse events were assessed. All patients were inoperable cases (six with pancreatic cancer [five, stage IV; one, stage III]; and one with gallbladder cancer [stage IV]) in whom CSEMs were inserted to treat refractory bleeding caused by cancer invasion. Hemostasis was achieved in all cases (100% [7/7]). The mean procedure time was 17 ± 7.9 min. There were no adverse events, including migration and rebleeding. No rebleeding occurred up until the time of death in any of the cases (mean follow‐up period, 73 ± 27 days). Deployment of duodenal CSEMS is a useful salvage therapy for bleeding caused by advanced pancreatobiliary cancer invasion. |
format | Online Article Text |
id | pubmed-10256867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102568672023-06-11 Utility of a partially covered metal stent for salvage sealing therapy for bleeding caused by duodenal invasion of pancreatobiliary cancers: Case series Yamashita, Yasunobu Yamazaki, Hirofumi Kawaji, Yuki Tamura, Takashi Hatamaru, Keiichi Itonaga, Masahiro Ashida, Reiko Kitano, Masayuki DEN Open Case Reports Pancreatobiliary cancer‐related gastrointestinal bleeding caused by duodenal invasion can be a life‐threatening condition that is hard to control. It is unclear whether a covered self‐expandable metal stent (CSEMS) is useful for hemostasis of bleeding related to advanced pancreatobiliary cancer. The aim of this study was to evaluate the utility of a CSEMS for hemostasis of bleeding caused by duodenal invasion of pancreatobiliary cancer. Between January 2020 and January 2022, seven patients in whom a duodenal CSEMS was inserted to control pancreatobiliary cancer‐related bleeding were enrolled. The technical and clinical success rates with respect to hemostasis, procedure time, and adverse events were assessed. All patients were inoperable cases (six with pancreatic cancer [five, stage IV; one, stage III]; and one with gallbladder cancer [stage IV]) in whom CSEMs were inserted to treat refractory bleeding caused by cancer invasion. Hemostasis was achieved in all cases (100% [7/7]). The mean procedure time was 17 ± 7.9 min. There were no adverse events, including migration and rebleeding. No rebleeding occurred up until the time of death in any of the cases (mean follow‐up period, 73 ± 27 days). Deployment of duodenal CSEMS is a useful salvage therapy for bleeding caused by advanced pancreatobiliary cancer invasion. John Wiley and Sons Inc. 2023-06-09 /pmc/articles/PMC10256867/ /pubmed/37304247 http://dx.doi.org/10.1002/deo2.253 Text en © 2023 The Authors. DEN Open published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Yamashita, Yasunobu Yamazaki, Hirofumi Kawaji, Yuki Tamura, Takashi Hatamaru, Keiichi Itonaga, Masahiro Ashida, Reiko Kitano, Masayuki Utility of a partially covered metal stent for salvage sealing therapy for bleeding caused by duodenal invasion of pancreatobiliary cancers: Case series |
title | Utility of a partially covered metal stent for salvage sealing therapy for bleeding caused by duodenal invasion of pancreatobiliary cancers: Case series |
title_full | Utility of a partially covered metal stent for salvage sealing therapy for bleeding caused by duodenal invasion of pancreatobiliary cancers: Case series |
title_fullStr | Utility of a partially covered metal stent for salvage sealing therapy for bleeding caused by duodenal invasion of pancreatobiliary cancers: Case series |
title_full_unstemmed | Utility of a partially covered metal stent for salvage sealing therapy for bleeding caused by duodenal invasion of pancreatobiliary cancers: Case series |
title_short | Utility of a partially covered metal stent for salvage sealing therapy for bleeding caused by duodenal invasion of pancreatobiliary cancers: Case series |
title_sort | utility of a partially covered metal stent for salvage sealing therapy for bleeding caused by duodenal invasion of pancreatobiliary cancers: case series |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256867/ https://www.ncbi.nlm.nih.gov/pubmed/37304247 http://dx.doi.org/10.1002/deo2.253 |
work_keys_str_mv | AT yamashitayasunobu utilityofapartiallycoveredmetalstentforsalvagesealingtherapyforbleedingcausedbyduodenalinvasionofpancreatobiliarycancerscaseseries AT yamazakihirofumi utilityofapartiallycoveredmetalstentforsalvagesealingtherapyforbleedingcausedbyduodenalinvasionofpancreatobiliarycancerscaseseries AT kawajiyuki utilityofapartiallycoveredmetalstentforsalvagesealingtherapyforbleedingcausedbyduodenalinvasionofpancreatobiliarycancerscaseseries AT tamuratakashi utilityofapartiallycoveredmetalstentforsalvagesealingtherapyforbleedingcausedbyduodenalinvasionofpancreatobiliarycancerscaseseries AT hatamarukeiichi utilityofapartiallycoveredmetalstentforsalvagesealingtherapyforbleedingcausedbyduodenalinvasionofpancreatobiliarycancerscaseseries AT itonagamasahiro utilityofapartiallycoveredmetalstentforsalvagesealingtherapyforbleedingcausedbyduodenalinvasionofpancreatobiliarycancerscaseseries AT ashidareiko utilityofapartiallycoveredmetalstentforsalvagesealingtherapyforbleedingcausedbyduodenalinvasionofpancreatobiliarycancerscaseseries AT kitanomasayuki utilityofapartiallycoveredmetalstentforsalvagesealingtherapyforbleedingcausedbyduodenalinvasionofpancreatobiliarycancerscaseseries |